BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15557408)

  • 1. Hormone therapy: making decisions in the face of uncertainty.
    Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
    Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone replacement therapy and breast cancer--any news?].
    Holli K
    Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
    [No Abstract]   [Full Text] [Related]  

  • 3. EMAS position statement: Managing the menopause in the context of coronary heart disease.
    Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
    Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
    Rosendaal FR
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHI and breast cancer: a response to a recent publication from the WHI.
    Pines A; Sturdee DW; Birkhäuser M;
    Climacteric; 2006 Aug; 9(4):244. PubMed ID: 16857654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy: where do we go from here?
    Jackson ME
    Ethn Dis; 2003; 13(3 Suppl 3):S3-48-9. PubMed ID: 14552451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement therapy and breast cancer].
    Mueck AO
    Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen replacement therapy and breast cancer.
    Maguire PJ
    J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy - where to from here? (with response from Sandra Coney).
    Fenton A
    N Z Med J; 2002 Sep; 115(1161):U163; discussion U163. PubMed ID: 12386670
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations for hormonal contraception. 34. Workshop of the "Zurich Discussion Circle", April 2005].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):58-63. PubMed ID: 16452822
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
    Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
    [No Abstract]   [Full Text] [Related]  

  • 20. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.